Mediclinic notes the announcement on 26 May 2021 by Ramsay (the “Firm Offer Announcement”) that it has reached an agreement on the terms of a recommended cash offer of 240 pence per Spire share pursuant to which Ramsay proposes to acquire the entire issued and to be issued ordinary share capital of Spire by way of a scheme of arrangement (the “Offer”). Under the terms of the Offer, the total cash consideration receivable by Mediclinic for its 29.9% interest in Spire would be £287.8m. The Offer is subject to certain conditions, including the approval of Spire shareholders. Mediclinic confirms it has provided an irrevocable undertaking to vote in favour of the Offer.

Refer to below announcement for more information. 

James Arnold

Head of Investor Relations
Mediclinic International plc
6th Floor
65 Gresham Street
London EC2V 7NQ
United Kingdom